T&D Pharmatech Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
11:00
Feb 11
Feb 11
Biotech rebound continues; favored names stay strong.
Biotech names were broadly strong and the rebound may continue; the speaker remains positive on Korean biotech, naming Alteogen, ABL Bio, and T&D Pharmatech as favored names.
MED
About T&D Pharmatech Investor Commentary
Across the available history and selected sources, Buzzberg tracks T&D Pharmatech across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Lee Kwon-hee.